Nature Communications Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020) Nielsen, J B, Rom, O, Surakka, I, Graham, S E, Zhou, W, Roychowdhury, T, Fritsche, L G, Taliun, S A G, Sidore, C, Liu, Y, Gabrielsen, M E, Skogholt, A H, Wolford, B, Overton, W, Zhao, Y, Chen, J, Zhang, H, Hornsby, W E, Acheampong, A, Grooms, A, Schaefer, A, Zajac, G J M, Villacorta, L, Zhang, J, Brumpton, B, Loset, M, Rai, V, Lundegaard, P R, Olesen, M S, Taylor, K D, Palmer, N D, Chen, Y-D, Choi, S H, Lubitz, S A, Ellinor, P T, Barnes, K C, Daya, M, Rafaels, N, Weiss, S T, Lasky-Su, J, Tracy, R P, Vasan, R S, Cupples, L A, Mathias, R A, Yanek, L R, Becker, L C, Peyser, P A, Bielak, L F, Smith, J A & Aslibekyan, S 2020, ' Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease ', Nature Communications, vol. 11, no. 1, 6417 . https://doi.org/10.1038/s41467-020-20086-3